Form 4/A for GLSI Greenwich LifeSciences, Inc.
Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0001493152-24-009164 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-03-07 | 2024-03-05 | GLSI | Patel Snehal | CEO, CFO, Dir, 10% | P - Purchase | $12.49 | +3,500 | 5.34M | +0.1% | +$43.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-05 | P | A | 3,500 | $12.49 | 5,343,777 | D | — | — |